Volker Neugebauer, MD, PhD, will use the grant from the National Institute of Neurological Disorders and Stroke to understand a process that causes hyperactivity in the amygdale and leads to persistent pain and anxiety.
Related Articles on Pain Management:
Convergence Pharmaceuticals Neuropatic Pain Drug Completes Phase I Trials
Trial for Boston Scientific’s Spinal Cord Stimulation Device Shows Promising Results
Oregon House Co-Speaker Visits Middle Fork Surgery Center for Pain Management Policy Discussion
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
